Stella Okoli is the CEO of Emzor Industries Nigeria Limited, a multi billion naira Pharmaceuticals business.
Emzor Pharmaceutical started off as a retailing chemist shop in January 1977 - with just N5,000 - and has grown to become a leading manufacturer of pharmaceutical products as well as other health and medical products. The company, a wholly owned indigenous company, was incorporated in Nigeria in 1984 for the purpose of manufacturing high-quality pharmaceutical products and medical consumables. It currently controls 25 per cent of the analgesic market in the country and produces over 60 time-tested products, which included analgesics, vitamins, haematinics, anti-malarials, anti-tussives, antibiotics, anti-helmintics, anti-histamine, antacid, and cardio-protective drugs in Nigeria and in the West Coast of Africa. Emzor Pharmaceuticals has established offices in India, Sierra Leone, Liberia, Ghana, and Mali.
Born in kano, Northern Nigeria, to Felix Ebelechukwu and Margaret Modebelu, of Nnewi, Anambra State, Okoli bagged a first degree in pharmacy from Bradford University, 1969, following it up with a master’s in Bio-Pharmaceutics from the University of London, Chelsea College, 1971. She has held several professional leadership positions, which include chairman of the Pharmaceutical Manufacturers Group, PMG, of Manufacturers Association of Nigeria, MAN; member, Nigeria Economic Summit, and member, Health Matters Advisory Board of Nigeria.
In terms of laurels, she is not lacking, parading various national and international recognitions, which include, Member Order of the Niger, MON, Fellow Pharmaceutical Society of Nigeria, Outstanding Service Award, Rotary International 21000, and ECOWAS International Gold Award.